KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,421,925 | -6.6% | 7,743 | -9.5% | 0.01% | -58.3% |
| Q1 2024 | $1,522,191 | +41.1% | 8,555 | -1.6% | 0.01% | +33.3% |
| Q4 2023 | $1,078,454 | +6.4% | 8,693 | -0.5% | 0.01% | 0.0% |
| Q3 2023 | $1,013,144 | -8.4% | 8,734 | -7.3% | 0.01% | -10.0% |
| Q2 2023 | $1,106,143 | +7.1% | 9,422 | -27.0% | 0.01% | 0.0% |
| Q1 2023 | $1,033,174 | -11.2% | 12,905 | -12.1% | 0.01% | -16.7% |
| Q4 2022 | $1,162,950 | -6.6% | 14,680 | -17.8% | 0.01% | -20.0% |
| Q3 2022 | $1,245,000 | +0.4% | 17,868 | -5.4% | 0.02% | +15.4% |
| Q2 2022 | $1,240,000 | -27.7% | 18,890 | -26.7% | 0.01% | -13.3% |
| Q1 2022 | $1,716,000 | -8.8% | 25,788 | -4.2% | 0.02% | -6.2% |
| Q4 2021 | $1,882,000 | +68.5% | 26,910 | +25.8% | 0.02% | +60.0% |
| Q3 2021 | $1,117,000 | -32.0% | 21,398 | -11.4% | 0.01% | -28.6% |
| Q2 2021 | $1,642,000 | -46.3% | 24,147 | -39.2% | 0.01% | -39.1% |
| Q1 2021 | $3,058,000 | -30.1% | 39,697 | -45.5% | 0.02% | +64.3% |
| Q4 2020 | $4,374,000 | – | 72,896 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $38,530,000 | 3.46% |
| S Squared Technology, LLC | 80,215 | $3,453,000 | 2.57% |
| First Light Asset Management, LLC | 464,663 | $20,004,000 | 2.05% |
| Redmile Group, LLC | 1,501,945 | $64,659,000 | 1.19% |
| Nicholas Investment Partners, LP | 222,422 | $9,575,000 | 1.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 184,573 | $7,946,000 | 0.78% |
| HighMark Wealth Management LLC | 18,894 | $813,000 | 0.73% |
| Hood River Capital Management LLC | 257,203 | $11,073,000 | 0.48% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 40,000 | $1,722,000 | 0.35% |
| Artal Group S.A. | 237,500 | $10,224,000 | 0.25% |